probenecid has been researched along with Polycythemia Vera in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Polycythemia Vera: A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LAPORTE, A | 1 |
| TANZER, J | 1 |
| ROSA, J | 1 |
1 other study available for probenecid and Polycythemia Vera
| Article | Year |
|---|---|
[Enhancement of penicillinemia as obtained with dipropylsulfamylbenzoic acid (probenecid, benamid) in three patients treated by a penicillin-streptomycin combination for malignant endocarditis].
Topics: Acute Disease; Endocarditis, Bacterial; Humans; Penicillins; Polycythemia Vera; Probenecid; Stomach; | 1957 |